Search Results for: Joachim Boldt

Is post-hoc statistical analysis the new fraud detection tool? A new review looks at fraudster Reuben’s work

In the beginning, there was Scott Reuben. Well, not quite. Reuben, a Massachusetts anesthesiologist who fabricated data and briefly topped our list of most-retracted authors, didn’t invent research fraud, although he did spend six months in federal prison for his crimes. But his case was in no small measure responsible for the birth of this … Continue reading Is post-hoc statistical analysis the new fraud detection tool? A new review looks at fraudster Reuben’s work

PLoS ONE expresses concern over flu vaccine paper

PLoS ONE has issued an expression of concern over a  2010 paper by Chinese scientists about how the immune system responds to the vaccine against the swine flu. The article, “Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine,” claimed to study 58 subjects given the inoculation (more on that … Continue reading PLoS ONE expresses concern over flu vaccine paper

Circulation retracts four papers by author who misled on IRB approval

Circulation has retracted four articles by a pediatric cardiologist in Japan who failed to obtain ethics approval for the studies in question but evidently lied about it to the journal. The researcher, Hideaki Senzaki, of Saitama Medical University, is a highly-published investigator who trained for a time with at Johns Hopkins. According to the Circulation … Continue reading Circulation retracts four papers by author who misled on IRB approval

Is misconduct more likely in drug trials than in other biomedical research?

A new paper by Chicago pharmacy researchers suggests that researchers performing drug studies are more likely to commit fraud than are their colleagues in the rest of biomedicine. In the paper, “Retraction Publications in the Drug Literature,” which appears in Pharmacotherapy, Jennifer C. Samp, Glen T. Schumock, and A. Simon Pickard take a look at … Continue reading Is misconduct more likely in drug trials than in other biomedical research?

Poldermans update: Magazine cites lack of informed consent, bogus patient surveys, invented data and more

Larry Husten at CardioBrief has an update on the case of Don Poldermans, a leading Dutch cardiologist who was accused of various iterations of research misconduct. Poldermans was fired last November by Erasmus Medical Center, where he had been head of perioperative cardiac care before the scandal. According to Husten, Jeroen Bax, another prominent Dutch cardiologist … Continue reading Poldermans update: Magazine cites lack of informed consent, bogus patient surveys, invented data and more

193 papers could be retracted: Journal consortium issues ultimatum in Fujii case

A group of editors representing nearly two dozen medical journals has issued an ultimatum of sorts to officials at seven Japanese institutions that once employed Yoshitaka Fujii: Validate the papers of the disgraced anesthesiologist or they will be retracted. Fujii, as we have reported, was fired by Toho University in late February, putatively for failing … Continue reading 193 papers could be retracted: Journal consortium issues ultimatum in Fujii case

Major fraud probe of Japanese anesthesiologist Yoshitaka Fujii may challenge retraction record

We have learned that a widely published Japanese anesthesiologist is under investigation by his university over concerns that he engaged in repeated fraud for decades that has tainted roughly 180 articles—many of which may be retracted as a result. In a related move, the journal Clinical Therapeutics is retracting papers by the researcher, Yoshitaka Fujii, most … Continue reading Major fraud probe of Japanese anesthesiologist Yoshitaka Fujii may challenge retraction record

The Anil Potti retraction record so far

A 60 Minutes segment Sunday on Anil Potti has drawn national attention to the case, so we thought this would be a good time to compile all of the retractions and corrections in one place. Duke has said that about a third of Potti’s 40-some-odd papers would be retracted, and another third would have “a … Continue reading The Anil Potti retraction record so far

Coming clean: A major figure in cardiology publishes a lengthy conflict of interest correction in JAMA

Authors’ financial disclosures can be a thorny issue for scientific journals.  There’s often confusion over just what should be listed as a conflict of interest, and when relationships are revealed after papers are published, lack of disclosure sometimes leads to corrections. For example, the Journal of Cell Science recently published this:

Anesthesia journal editor says “if you blow us off, it will be retracted,” and sticks to his word

The Journal of Clinical Anesthesia has retracted a paper by a group of Israeli authors whose study may not have had appropriate ethical approval — or even collected the reported data. The article, “Accidental venous and dural puncture during epidural analgesia in obese parturients (BMI > 40 kg/m2): three different body positions during insertion,” was … Continue reading Anesthesia journal editor says “if you blow us off, it will be retracted,” and sticks to his word